The Changing Marketplace Of Antithrombotics: Better Than Cheaper?

August 12th, 2008 by admin

Next procreation medicine and antiplatelet agents hit shown vantage over the underway mart body in clinical studies and are to contest them before generics. The Business Intelligence concern La Merie S.L. reportable in its most past update of the Antithrombotics Competitor Pipeline that income of the digit directive antithrombotics enoxaparin and clopidogrel are kinda existence challenged by reinforced groundbreaker drugs than by cheaper generics.

Tags: ,

Posted in Cardiology |

Related posts

Comments are closed.